|
Volume 272, Number 49,
Issue of December 5, 1997
pp. 31036-31042
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
The Membrane-bound Form of Heparin-binding Epidermal Growth
Factor-like Growth Factor Promotes Survival of Cultured Renal
Epithelial Cells
(Received for publication, March 25, 1997, and in revised form, August 29, 1997)
Tsukasa
Takemura
,
Satoshi
Kondo
,
Toshio
Homma
,
Masahiro
Sakai
and
Raymond C.
Harris
From the Department of Medicine, Vanderbilt University School of
Medicine and the Department of Veterans Affairs Medical Center,
Nashville, Tennessee 37232
To understand whether expression of
membrane-anchored heparin binding epidermal growth factor (proHB-EGF)
is involved in renal epithelial cell survival, rat membrane-bound
HB-EGF precursor was stably transfected into a renal epithelial cell
line, NRK 52E cells (NRKproHB-EGF). When exposed to
10% fetal calf serum (FCS), there were no differences in growth rates
among wild-type (WT), vector-transfected (NRKvector), and
NRKproHB-EGF. However, when cells were grown in the
presence of 1% FCS, the growth rate of NRKproHB-EGF was
65% faster. When confluent cell monolayers were exposed to H2O2 or etoposide, WT or NRKvector
exhibited significant apoptotic bodies and DNA laddering; in contrast,
NRKproHB-EGF were resistant to both stimuli, as indicated
by increased cell viability and marked decrease of apoptotic bodies and
DNA laddering. When plated at high density onto plastic dishes without
FCS, WT and NRKvector formed few attachments, did not
proliferate, and underwent apoptosis. By day 3, no cells survived.
Addition of exogenous recombinant HB-EGF (10 8
M) to WT or NRKvector increased cell survival
by <10% and incubation with conditioned media of
NRKproHB-EGF had no effect. In contrast,
NRKproHB-EGF attached and formed epithelial colonies,
although they did not proliferate. After 3 days, cell viability was
84% of the initial cell number plated, and no evidence of apoptosis
was present. When plated in 10% FCS, NRKproHB-EGF
attachment to plastic substratum at 1, 2, and 3 h was 250%
greater than that of WT or NRKvector. Addition of exogenous
recombinant human HB-EGF to WT or NRKvector increased
attachment by <50%. When grown on poly(2-hydroxyethyl methacrylate)
or in the presence of the integrin receptor-blocking peptide GRGDTP,
neither WT nor NRKvector attached to the substratum or
formed cell-cell attachments. Compared with WT or
NRKvector, NRKproHB-EGF exhibited 300% greater
cell viability on either poly(2-hydroxyethyl methacrylate)-coated
dishes or in the presence of GRGDTP and formed cell clusters. When
plated at low density (1 × 103 cells/1.5-cm dish) or
at high density in the presence of an anti-HB-EGF blocking antibody,
NRKproHB-EGF failed to form epithelial colonies. Addition
of formalin fixed NRKproHB-EGF promoted EGF receptor
tyrosine phosphorylation in quiescent A431 cells and stimulated DNA
synthesis and prevented H2O2-induced apoptosis
in renal epithelial cells. These results indicate that membrane-bound
HB-EGF promotes renal epithelial cell survival, possibly by promoting
cell-matrix and cell-cell interactions. The failure of either
conditioned media or exogenous HB-EGF to reproduce these findings
suggests that juxtacrine or tightly coupled paracrine interactions
underlie this cytoprotection.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. B. Singh, K. Sugimoto, and R. C. Harris
Juxtacrine Activation of Epidermal Growth Factor (EGF) Receptor by Membrane-anchored Heparin-binding EGF-like Growth Factor Protects Epithelial Cells from Anoikis While Maintaining an Epithelial Phenotype
J. Biol. Chem.,
November 9, 2007;
282(45):
32890 - 32901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Singh, K. Sugimoto, P. Dhawan, and R. C. Harris
Juxtacrine activation of EGFR regulates claudin expression and increases transepithelial resistance
Am J Physiol Cell Physiol,
November 1, 2007;
293(5):
C1660 - C1668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-S. Kim, M. S. Kim, A. L. Hancock, J. C. P. Harper, J. Y. Park, G. Poy, A. O. Perantoni, M. Cam, K. Malik, and S. B. Lee
Identification of Novel Wilms' Tumor Suppressor Gene Target Genes Implicated in Kidney Development
J. Biol. Chem.,
June 1, 2007;
282(22):
16278 - 16287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. E. Willmarth and S. P. Ethier
Autocrine and Juxtacrine Effects of Amphiregulin on the Proliferative, Invasive, and Migratory Properties of Normal and Neoplastic Human Mammary Epithelial Cells
J. Biol. Chem.,
December 8, 2006;
281(49):
37728 - 37737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Conti, M. Hsieh, J.-Y. Park, and Y.-Q. Su
Role of the Epidermal Growth Factor Network in Ovarian Follicles
Mol. Endocrinol.,
April 1, 2006;
20(4):
715 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Akayama, S. Takekida, N. Ohara, H. Tateiwa, W. Chen, K. Nakabayashi, and T. Maruo
Gene expression and immunolocalization of heparin-binding epidermal growth factor-like growth factor and human epidermal growth factor receptors in human corpus luteum
Hum. Reprod.,
October 1, 2005;
20(10):
2708 - 2714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. B. Mehta and G. E. Besner
Heparin-Binding Epidermal Growth Factor-Like Growth Factor Inhibits Cytokine-Induced NF-{kappa}B Activation and Nitric Oxide Production via Activation of the Phosphatidylinositol 3-Kinase Pathway
J. Immunol.,
August 1, 2005;
175(3):
1911 - 1918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, N. Ohara, S. Takekida, Q. Xu, and T. Maruo
Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells
Hum. Reprod.,
June 1, 2005;
20(6):
1456 - 1465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dong, L. K. Opresko, W. Chrisler, G. Orr, R. D. Quesenberry, D. A. Lauffenburger, and H. S. Wiley
The Membrane-anchoring Domain of Epidermal Growth Factor Receptor Ligands Dictates Their Ability to Operate in Juxtacrine Mode
Mol. Biol. Cell,
June 1, 2005;
16(6):
2984 - 2998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pyka, A. Glogowska, H. Dralle, C. Hoang-Vu, and T. Klonisch
Cytoplasmic Domain of proEGF Affects Distribution and Post-Translational Modification of Microtubuli and Increases Microtubule-Associated Proteins 1b and 2 Production in Human Thyroid Carcinoma Cells
Cancer Res.,
February 15, 2005;
65(4):
1343 - 1351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Hinkle, S. W. Sunnarborg, D. Loiselle, C. E. Parker, M. Stevenson, W. E. Russell, and D. C. Lee
Selective Roles for Tumor Necrosis Factor {alpha}-converting Enzyme/ADAM17 in the Shedding of the Epidermal Growth Factor Receptor Ligand Family: THE JUXTAMEMBRANE STALK DETERMINES CLEAVAGE EFFICIENCY
J. Biol. Chem.,
June 4, 2004;
279(23):
24179 - 24188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Singh, T. Tsukada, R. Zent, and R. C. Harris
Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells
J. Cell Sci.,
March 15, 2004;
117(8):
1365 - 1379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Wang, J.-K. Chen, S.-w. Wang, G. Moeckel, and R. C. Harris
Importance of Functional EGF Receptors in Recovery from Acute Nephrotoxic Injury
J. Am. Soc. Nephrol.,
December 1, 2003;
14(12):
3147 - 3154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. B. Mehta and G. E. Besner
Inhibition of NF-{kappa}B Activation and Its Target Genes by Heparin-Binding Epidermal Growth Factor-Like Growth Factor
J. Immunol.,
December 1, 2003;
171(11):
6014 - 6022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Ingram, A. B. Rice, J. Santos, B. Van Houten, and J. C. Bonner
Vanadium-induced HB-EGF expression in human lung fibroblasts is oxidant dependent and requires MAP kinases
Am J Physiol Lung Cell Mol Physiol,
May 1, 2003;
284(5):
L774 - L782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Nolan, N. DiGirolamo, N. H. Sachdev, T. Hampartzoumian, M. T. Coroneo, and D. Wakefield
The Role of Ultraviolet Irradiation and Heparin-Binding Epidermal Growth Factor-Like Growth Factor in the Pathogenesis of Pterygium
Am. J. Pathol.,
February 1, 2003;
162(2):
567 - 574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Adam, T. Danciu, D. L. McLellan, J. G. Borer, J. Lin, D. Zurakowski, M. H. Weinstein, P. H. Rajjayabun, J. K. Mellon, and M. R. Freeman
A Nuclear Form of the Heparin-binding Epidermal Growth Factor-like Growth Factor Precursor Is a Feature of Aggressive Transitional Cell Carcinoma
Cancer Res.,
January 15, 2003;
63(2):
484 - 490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Chobotova, M.-E. Muchmore, J. Carver, H.-J Yoo, S. Manek, W. J. Gullick, D. H. Barlow, and H. J. Mardon
The Mitogenic Potential of Heparin-Binding Epidermal Growth Factor in the Human Endometrium Is Mediated by the Epidermal Growth Factor Receptor and Is Modulated by Tumor Necrosis Factor-{alpha}
J. Clin. Endocrinol. Metab.,
December 1, 2002;
87(12):
5769 - 5777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Uesaka, H. Lu, O. Katoh, and H. Watanabe
Heparin-binding EGF-like growth factor gene transcription regulated by Cdx2 in the intestinal epithelium
Am J Physiol Gastrointest Liver Physiol,
October 1, 2002;
283(4):
G840 - G847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Robey, J. Ma, A. V. P. Santos, O. A. Noboa, P. E. Coy, and J. M. Bryson
Regulation of Mesangial Cell Hexokinase Activity and Expression by Heparin-binding Epidermal Growth Factor-like Growth Factor. EPIDERMAL GROWTH FACTORS AND PHORBOL ESTERS INCREASE GLUCOSE METABOLISM VIA A COMMON MECHANISM INVOLVING CLASSIC MITOGEN-ACTIVATED PROTEIN KINASE PATHWAY ACTIVATION AND INDUCTION OF HEXOKINASE II EXPRESSION
J. Biol. Chem.,
April 19, 2002;
277(17):
14370 - 14378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. L. Bryant, J. E. Schmid, S. E. Fenton, A. R. Buckalew, and B. D. Abbott
Teratogenicity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in Mice Lacking the Expression of EGF and/or TGF-{{alpha}}
Toxicol. Sci.,
July 1, 2001;
62(1):
103 - 114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. TAKEMURA, S. HINO, H. KUWAJIMA, H. YANAGIDA, M. OKADA, M. NAGATA, S. SASAKI, J. BARASCH, R. C. HARRIS, and K. YOSHIOKA
Induction of Collecting Duct Morphogenesis In Vitro by Heparin-Binding Epidermal Growth Factor-Like Growth Factor
J. Am. Soc. Nephrol.,
May 1, 2001;
12(5):
964 - 972.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. J. HAMPEL, C. SANSOME, M. SHA, S. BRODSKY, W. E. LAWSON, and M. S. GOLIGORSKY
Toward Proteomics in Uroscopy: Urinary Protein Profiles after Radiocontrast Medium Administration
J. Am. Soc. Nephrol.,
May 1, 2001;
12(5):
1026 - 1035.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Tokumaru, S. Higashiyama, T. Endo, T. Nakagawa, J.-i. Miyagawa, K. Yamamori, Y. Hanakawa, H. Ohmoto, K. Yoshino, Y. Shirakata, et al.
Ectodomain Shedding of Epidermal Growth Factor Receptor Ligands Is Required for Keratinocyte Migration in Cutaneous Wound Healing
J. Cell Biol.,
October 9, 2000;
151(2):
209 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dixit, M. E. Nasrallah, and J. B. Nasrallah
Post-Transcriptional Maturation of the S Receptor Kinase of Brassica Correlates with Co-Expression of the S-Locus Glycoprotein in the Stigmas of Two Brassica Strains and in Transgenic Tobacco Plants
Plant Physiology,
September 1, 2000;
124(1):
297 - 312.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Kanellis, S. Fraser, M. Katerelos, and D. A. Power
Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells
Am J Physiol Renal Physiol,
June 1, 2000;
278(6):
F905 - F915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. T. Nguyen, S. H. Bride, A.-B. Badawy, R. M. Adam, J. Lin, A. Orsola, P. D. Guthrie, M. R. Freeman, and C. A. Peters
Heparin-Binding EGF-Like Growth Factor Is Up-Regulated in the Obstructed Kidney in a Cell- and Region-Specific Manner and Acts to Inhibit Apoptosis
Am. J. Pathol.,
March 1, 2000;
156(3):
889 - 898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dong and H. S. Wiley
Trafficking and Proteolytic Release of Epidermal Growth Factor Receptor Ligands Are Modulated by Their Membrane-anchoring Domains
J. Biol. Chem.,
January 7, 2000;
275(1):
557 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kamimura, Y. Konda, H. Yokota, S.-I. Takenoshita, Y. Nagamachi, H. Kuwano, and T. Takeuchi
Kex2 family endoprotease furin is expressed specifically in pit-region parietal cells of the rat gastric mucosa
Am J Physiol Gastrointest Liver Physiol,
July 1, 1999;
277(1):
G183 - G190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lin, L. Hutchinson, S. M. Gaston, G. Raab, and M. R. Freeman
BAG-1 Is a Novel Cytoplasmic Binding Partner of the Membrane Form of Heparin-binding EGF-like Growth Factor. A UNIQUE ROLE FOR proHB-EGF IN CELL SURVIVAL REGULATION
J. Biol. Chem.,
August 3, 2001;
276(32):
30127 - 30132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Oka, K. Tagoku, T. L. Russell, Y. Nakano, T. Hamazaki, E. M. Meyer, T. Yokota, and N. Terada
CD9 Is Associated with Leukemia Inhibitory Factor-mediated Maintenance of Embryonic Stem Cells
Mol. Biol. Cell,
April 1, 2002;
13(4):
1274 - 1281.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|